schizandrin c has been researched along with Benign Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Gui, S; Guo, J; He, G; Li, Z; Lv, X; Ma, X; Tao, Q; Tao, Y; Wei, W; Zhang, M | 1 |
Chang, JB; Li, YF; Wang, Q | 1 |
1 review(s) available for schizandrin c and Benign Neoplasms
Article | Year |
---|---|
Synthesis and biological activity of Wuweizisu C and analogs.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Biological Products; Cyclooctanes; Hepatitis B; Humans; Lignans; Neoplasms; Polycyclic Compounds | 2009 |
1 other study(ies) available for schizandrin c and Benign Neoplasms
Article | Year |
---|---|
SAR study culminates in a series of HDAC6 selective inhibitors featuring Schisandrin C-analogous Cap as potential immunomodulatory agents for cancer therapy.
Topics: Animals; Antineoplastic Agents; Cyclooctanes; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Immunomodulating Agents; Lignans; Neoplasms; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2022 |